Efficacy data in treatment extension studies of idiopathic pulmonary fibrosis: interpret with caution
- PMID: 30224324
- DOI: 10.1016/S2213-2600(18)30385-0
Efficacy data in treatment extension studies of idiopathic pulmonary fibrosis: interpret with caution
Comment on
-
Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON.Lancet Respir Med. 2019 Jan;7(1):60-68. doi: 10.1016/S2213-2600(18)30339-4. Epub 2018 Sep 14. Lancet Respir Med. 2019. PMID: 30224318 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
